What is the ONLY Long acting Beta 2 agonist on the NBEO outline that is used for maintenance of COPD and asthma?

Prepare for the KMK Live Session General Pharmacy Test. Use flashcards and multiple-choice questions with hints and explanations for each question. Get ready for your exam with confidence!

Multiple Choice

What is the ONLY Long acting Beta 2 agonist on the NBEO outline that is used for maintenance of COPD and asthma?

Explanation:
Long-acting beta-2 agonists provide ongoing bronchodilation to keep airways open on a regular basis, not for immediate relief. Salmeterol fits this role because it delivers sustained bronchodilation for about 12 hours, making it suitable for maintenance therapy in both COPD and asthma. It’s taken regularly (usually twice daily) and is not a rescue inhaler during an acute attack. In asthma, it’s typically used in combination with an inhaled corticosteroid to improve control, and in COPD it helps reduce symptoms and exacerbations as part of maintenance therapy. The other options are either short-acting, used for quick relief, or, in the case of another long-acting agent, not the one referenced in this NBEO item.

Long-acting beta-2 agonists provide ongoing bronchodilation to keep airways open on a regular basis, not for immediate relief. Salmeterol fits this role because it delivers sustained bronchodilation for about 12 hours, making it suitable for maintenance therapy in both COPD and asthma. It’s taken regularly (usually twice daily) and is not a rescue inhaler during an acute attack. In asthma, it’s typically used in combination with an inhaled corticosteroid to improve control, and in COPD it helps reduce symptoms and exacerbations as part of maintenance therapy. The other options are either short-acting, used for quick relief, or, in the case of another long-acting agent, not the one referenced in this NBEO item.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy